Back to search

Article

Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotype

2024-11-26

Abstract excerpt

<title>Abstract</title> <p>Prostate cancer (PCa) is the most common non-cutaneous malignancy and the second leading cause of cancer-related death in men. Despite its prevalence, treatment outcomes are often unsatisfactory, necessitating the search for more effective therapeutic approaches. mTOR inhibitor Rapamycin (RAPA) has shown promise in managing PCa, but the emergence of resistance often undermines its long-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a35949d-1605-5a2b-934d-ae2ae235f8d8
DOI
10.21203/rs.3.rs-5399970/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotypeDOI 10.21203/rs.3.rs-5399970/v1
Select a neighboring publication to make it the new centre.